Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden

Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer

(2018) Min Young Baek et al.   KOREAN JOURNAL OF INTERNAL MEDICINE

The impact of brain metastasis on quality of life, resource utilization and survival in patients with non-small-cell lung cancer

(2016) Solange Peters et al.   CANCER TREATMENT REVIEWS

A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis?

(2016) Guang Han et al.   Oncotarget

Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden

(2015) Annie Guérin et al.   JOURNAL OF MEDICAL ECONOMICS

A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER)

(2014) Yuankai Shi et al.   Journal of Thoracic Oncology

Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival

(2014) Karmen Stanic et al.   Radiology and Oncology

Impact of Brain Metastases on Quality of Life and Estimated Life Expectancy in Patients with Advanced Non-Small Cell Lung Cancer

(2014) A. Roughley et al.   VALUE IN HEALTH

A systematic review of the cost-effectiveness of targeted therapies for metastatic non-small cell lung cancer (NSCLC)

(2014) Ansgar Lange et al.   BMC Pulmonary Medicine

Radiation therapy remains the key cost driver of oncology inpatient treatment

(2014) Mihajlo Jakovljevic et al.   JOURNAL OF MEDICAL ECONOMICS

Survival of patients with non-small-cell lung cancer after a diagnosis of brain metastases

(2013) A. Ali et al.   Current Oncology

Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma WithEGFRMutations

(2013) Lecia V. Sequist et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative analysis of survival, treatment, cost and resource use among patients newly diagnosed with brain metastasis by initial primary cancer

(2013) Saurabh Ray et al.   JOURNAL OF NEURO-ONCOLOGY

The Impact of Initial Gefitinib or Erlotinib versus Chemotherapy on Central Nervous System Progression in Advanced Non-Small Cell Lung Cancer with EGFR Mutations

(2012) S. Heon et al.   CLINICAL CANCER RESEARCH

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

(2012) Rafael Rosell et al.   LANCET ONCOLOGY

Healthcare costs in patients with metastatic lung cancer receiving chemotherapy

(2011) Montserrat Vera-Llonch et al.   BMC HEALTH SERVICES RESEARCH

Incidence ofEGFRExon 19 Deletions and L858R in Tumor Specimens From Men and Cigarette Smokers With Lung Adenocarcinomas

(2011) Sandra P. D'Angelo et al.   JOURNAL OF CLINICAL ONCOLOGY

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

(2011) Paul W. Sperduto et al.   JOURNAL OF CLINICAL ONCOLOGY

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

(2011) Caicun Zhou et al.   LANCET ONCOLOGY

Development of Central Nervous System Metastases in Patients with Advanced Non-Small Cell Lung Cancer and Somatic EGFR Mutations Treated with Gefitinib or Erlotinib

(2010) S. Heon et al.   CLINICAL CANCER RESEARCH

Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

(2010) Martin J. Edelman et al.   Journal of Thoracic Oncology

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Resource Utilization in Patients with Brain Metastases Managed with Best Supportive Care, Radiotherapy and/or Surgical Resection: A Markov Analysis

(2010) Carsten Nieder et al.   ONCOLOGY

Every-day clinical practice in patients with advanced non-small-cell lung cancer

(2009) V. Zietemann et al.   LUNG CANCER

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Emerging ethnic differences in lung cancer therapy

(2008) I Sekine et al.   BRITISH JOURNAL OF CANCER

Costs associated with intravenous chemotherapy administration in patients with small cell lung cancer: a retrospective claims database analysis

(2008) Mei Sheng Duh et al.   CURRENT MEDICAL RESEARCH AND OPINION

Memory Function Before and After Whole Brain Radiotherapy in Patients With and Without Brain Metastases

(2008) Grit Welzel et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Rehabilitation in primary and metastatic brain tumours

(2008) V. Tang et al.   JOURNAL OF NEUROLOGY

Caring for the brain tumor patient: Family caregiver burden and unmet needs

(2007) Jane R. Schubart et al.   NEURO-ONCOLOGY